
Desvenlafaxine
50 mg/1 · Extended-Release Tablet
By Alembic Pharmaceuticals Limited
- NDC
- 46708-152
- Route
- Oral
- Therapeutic class
- Cytochrome P450 2D6 Inhibitors [MoA], Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor
- Marketing category
- NDA
Additional information
Full prescribing information for this product is available on request. Submit a sourcing request and our team will share lot details, dating, and current pricing.
Request this medication
Send a request and we'll respond with availability, lot details, and pricing within 2 business hours.

